Monday, 23 December 2013

PEPFAR

U.S. President’s Emergency Plan for AIDS Relief
“The United States of America will remain the global leader in the fight against HIV and
AIDS. We will stand with you every step of this journey until...we achieve, at long last, what
was once hard to imagine -- and that’s an AIDS-free generation.
-
President Barack Obama, December 2, 2013
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) represents America’s commitment to
saving lives and the shared responsibility of all global partners toward achieving an AIDS-Free Generation.
■
As of September 30, 2013, PEPFAR is supporting
life-saving antiretroviral
treatment for
6.7 million men, women, and children worldwide.
This far exceeds
President Obama’s 2011 World AIDS Day goal of 6 million people on treatment -- a
four-fold increase
(from 1.7 million in 2008) since the start of this Administration.
■
In Fiscal Year (FY) 2013, PEPFAR supported
HIV testing and counseling for more
than 12.8 million pregnant women
. For 780,000 of these women who tested positive
for HIV, PEPFAR provided antiretroviral medications to prevent mother-to-child
transmission (PMTCT) of the virus. Due to PEPFAR support,
95 percent of these
babies were born HIV-free
(including 240,000 that would otherwise have been infected).
 Over
the
past
two
years,
over 1.5 million HIV-positive pregnant
women received these interventions to prevent mother-to-child transmission
and improve maternal health, meeting the President’s 2011 World AIDS Day goal.
■
As of September 30, 2013, PEPFAR will have supported
more than 4.2 million voluntary
medical male circumcision (VMMC) procedures
in east and southern Africa; by the end of
2013, PEPFAR will have reached the President’s 2011 World AIDS Day VMMC goal of
4.7 million
.
■
PEPFAR supported
17 million people with care and support
, including
more than 5 million orphans and vulnerable children
, in FY 2013.
■
PEPFAR supported
HIV testing and counseling for more than 57.7 million
people
in FY 2013, providing a critical entry point to prevention, treatment, and care.
■
The
U.S.
is
the
first
and
largest
donor
to
the
Global Fund to Fight AIDS, Tuberculosis and
Malaria.
As
a
result
of
the
significant
investment
by
the
U.S.
in
the
Global
Fund,
of
the
estimated
9.7
million
individuals in low- and middle-income countries who currently receive treatment,
nearly
9.1 million
receive support
through PEPFAR bilateral programs, the Global Fund, or both.
www.PEPFAR.gov
Shared Responsibility-Strengthening Results
For An AIDS-Free Generation
2013 PEPFAR Results

Making prevention and treatment possible

HIV and AIDS

Since the launch of USAID's HIV and AIDS program in 1986, the Agency has been on the forefront of the global AIDS crisis.
Today, with more than 34 million people living with HIV worldwide, USAID is a key partner in the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest and most diverse HIV and AIDS prevention, care and treatment initiative in the world.
As a result of PEPFAR, USAID and other implementing partners have:
  • Provided lifesaving AIDS treatment to more than 5.1 million people and HIV counseling and testing to more than 46.5 million people.
  • Supported more than 11 million pregnant women with HIV testing and counseling and provided prevention of mother-to-child transmission (PMTCT) services to more than 750,000 HIV-positive women. As a result approximately 230,000 infants were born free of HIV.
  • Reached nearly 15 million people with care and support, including more than 4.5 million orphans and vulnerable children.
  • Supported approximately 2 million male circumcision procedures worldwide cumulatively.
Our Work [PDF, 183KB]: Learn more about our efforts in the fight against HIV and AIDS and chart the course of USAID's work in our interactive timeline.
It Takes A Village. Empowering Communities to Fight HIV: Read about USAID's long history in working with communities in combating HIV and AIDS.
Reflections and Impressions from AIDS 2012: Read our insights from last year's conference in D.C.
Related Sectors of Work 
Last updated: December 02, 2013

World AIDS Day

Treatment to those who need it most

Antiretroviral Therapy

Researcher showing young boy HIV treatment drugs
EGPAF/James Pursey

DELIVERING LIFESAVING HIV TREATMENT TO THOSE WHO NEED IT MOST

HIV continues to be one of the deadliest infectious diseases in the world. At the end of 2011, 34 million people were living with HIV, with approximately 69 percent of them living in sub-Saharan Africa. Worldwide, an estimated 2.5 million people became newly infected with HIV in 2011. Without treatment, HIV infection progresses to AIDS in approximately 8 years; once diagnosed with AIDS, median life expectancy is under 2 years.
Antiretroviral therapy (ART) stops the replication of the HIV virus inside a person infected with HIV, affording the body’s immune system time to recover and rebuild itself. While not curative, these medicines are dramatically powerful, with studies suggesting that HIV-positive patients in resource- limited settings can achieve near-normal life expectancies when taking ART. In addition, by lowering the amount of HIV virus in the body, antiretroviral drugs (ARVs) help reduce the chance that an HIV-positive individual transmits the infection to an HIV-negative partner.

THE USAID RESPONSE: ROBUST ANTIRETROVIRAL THERAPY PROGRAMS TO IMPROVE HEALTH, REDUCE TRANSMISSION AND BUILD STRONGER HEALTH SYSTEMS

In spite of the severity of the challenges posed by the epidemic, access to antiretroviral therapy globally has increased substantially since 2003 to over 8 million people, with over 5 million people supported directly by U.S. Government assistance under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). The number of AIDS-related deaths in sub-Saharan Africa declined by nearly one-third between 2005 and 2011. The U.S. Government is the world’s largest donor to HIV and AIDS programs worldwide, having provided over $36 billion through PEPFAR through FY 2012, with much of that support managed by the U.S. Agency for International Development (USAID). As PEPFAR’s largest implementing agency, USAID supports comprehensive ART programs to improve access to quality HIV care and treatment services – including antiretroviral medicines – for individuals living with HIV.
USAID-supported ART programs focus on three key priorities:
Photo of a woman in a wheel chair with a young boy
USAID/Senegal
  1. Improving Access to ART for individuals living with HIV
  2. Improving the Quality of ART services
  3. Fostering Sustainability of lifelong HIV treatment services
To accomplish these priorities, USAID and its implementing partners have utilized a variety of innovative programmatic approaches. They include:
  • Pooling procurement and utilizing generic antiretroviral medicines to lower the price of HIV medicines in resource-limited settings 10-fold.
  • Using new technologies such as mobile phones to help support patient adherence to medication and engagement with health services.
  • Making care more accessible through mobile outreach and patient support.
  • Task sharing among groups of health care workers to ensure patients can receive the services they need.
  • Developing robust information systems for clinical settings and for the management of commodities; using these systems to improve the quality of care provided to patients.

FUTURE DIRECTIONS

In order to meet the substantial need for ART, USAID is actively working on projects to increase the efficiency of treatment programs while simultaneously improving program quality.
Essential HIV and AIDS medicines and supplies flow through this SCMS warehouse.
Essential HIV and AIDS medicines and supplies flow through this SCMS warehouse.
PHD
  • The USAID Supply Chain Management Systems (SCMS) project is harnessing the power of pooled forecasting and procurement beyond ARVs to include critical diagnostic laboratory supplies. In addition, the project continues to work closely with host country logistics systems to improve their capacity to forecast, procure, store and distribute key commodities. In close collaboration with other U.S. Government partners, the SCMS project operates an Emergency Commodities Fund to mitigate potential stock-outs of ARVs and rapid HIV test kits.
  • USAID is supporting implementation science and operations research through studies looking at linking patients to care and treatment, retention and integration of ART services.
  • Through mechanisms like the Health Finance and Governance Project, USAID is providing support for cost-modeling to help inform governments, country teams and implementing partners in planning for future commitments and maximizing the impact of available resources. This includes planning for changes in national guidelines in 2013 and in the adoption and spread of new technologies for improving care, such as HIV viral load testing.
For more information on HIV treatment programs, please see the Treatment Issue Brief [PDF, 197KB].
Last updated: October 17, 2013
Share This Page

Maternal, newborn, child and adolescent health

Maternal, newborn, child and adolescent health

Ending preventable child deaths from pneumonia and diarrhoea by 2025

The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD)

Share
Authors:
WHO/UNICEF
Publication cover image

Publication details

Number of pages: 64 (16)
Publication date: 2013
Languages: English, French
ISBN: 978 92 4 150523 9

Downloads

Overview

Stopping the loss of millions of young lives from pneumonia and diarrhoea is a goal within our grasp. The integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) proposes a cohesive approach to ending preventable pneumonia and diarrhoea deaths. It brings together critical services and interventions to create healthy environments, promotes practices known to protect children from disease and ensures that every child has access to proven and appropriate preventive and treatment measures.
The goal is ambitious but achievable: to end preventable childhood deaths due to pneumonia and diarrhoea by 2025.

Related publications